Scott Ramsey
Internal Medicine · Seattle, WANPI 1538256896
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $201,066 of the $230,202 with a category attached, or 87.3%. Bayer accounts for 66.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $44,118 and has fallen 54.9% since, to $19,902 in 2025. Among internal medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 254 payments — averaging $906.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$154K
- Merck$45K
- Pfizer$16K
- Regeneron$6K
- E.r. Squibb & Sons, L.L.C.$5K
- AstraZeneca$2K
- plus $2K from 4 others
Across 11 payments — averaging $165,012 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$1.8M
- AstraZeneca$26K
- Astrazeneca UK Limited$1K
What the payments were for
- Consulting fees$201,06687%
- Speaking & faculty fees$5,0002%
- Travel & lodging$16,6477%
- Food & beverage$7,4903%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 213 | $153,679 |
| Merck | 26 | $45,000 |
| Pfizer | 5 | $16,075 |
| Regeneron | 4 | $5,560 |
| E.r. Squibb & Sons, L.L.C. | 1 | $5,000 |
| AstraZeneca | 1 | $2,400 |
| Boehringer Ingelheim | 1 | $2,385 |
| Novo Nordisk | 1 | $41 |
| Illumina, Inc. | 1 | $39 |
| Genentech USA, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$83,660
- Non-Covered$20,951
- IBRANCE$16,075
- KEYTRUDA$12,000
- IMFINZI$2,400
How this compares
$230,202 in reported general payments places this provider in the 95th percentile of 2,038 internal medicine providers in Washington.
Other internal medicine in Seattle
- Peter ShalitSeattle$1M
- Michael CairnsSeattle$144K
- Peiqing QianSeattle$117K
- Kevin ChungSeattle$35K
- David DaleSeattle$35K
- Catherine BenzigerSeattle$13K
- Christopher DoddSeattle$12K
- Dedra BuchwaldSeattle$11K
- Thao NguyenSeattle$10K
- James FloydSeattle$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.